Ronald M. (Hrsg.) Bukowski

Renal Cell Carcinoma

Molecular Targets and Clinical Applications

Buch

???The third edition of this critically acclaimed book has updated and expanded the survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. Internationally renowned editors and contributors explore the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors.Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Third Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by leaders of the field.?

CHF 197.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

V103: Folgt in ca. 5 Arbeitstagen

Produktdetails

Weitere Autoren: Motzer, Robert J. (Hrsg.) / Figlin, Robert A. (Hrsg.)

ISBN: 978-1-4939-5063-8
EAN: 9781493950638
Produktnummer: 20404879
Verlag: Springer New York
Sprache: Englisch
Erscheinungsjahr: 2016
Seitenangabe: 632 S.
Masse: H23.5 cm x B15.5 cm x D3.3 cm 943 g
Auflage: Softcover reprint of the original 3rd ed. 2015
Abbildungen: Paperback
Gewicht: 943

Über den Autor

Ronald M Bukowski MDEmeritus Staff PhysicianCleveland Clinic Taussig Cancer CenterProfessor Emeritus of MedicineCCF Lerner College of Medicine of CWRU Robert Figlin MDProfessor of Medicine and Biomedical SciencesDirector, Division of Hematology OncologyDepartment of Medicine, Cedars-Sinai Medical CenterAssociate Director for Academic ProgramsSamuel Oschin Comprehensive Cancer InstituteProfessor Emeritus of Medicine and UrologyDavid Geffen School of Medicine at UCLA Robert Motzer MDAttending PhysicianDepartment of MedicineMemorial Sloan-Kettering Cancer CenterProfessor of MedicineWeil Medical College of Cornell University